Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products > Novel inhibitors

Novel inhibitors

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC1124 Brd3316
Novel inhibitor of parasite phenylalanyl-tRNA synthetase (PheRS)
More description
DCC1123 Brd3067
Negative control for tubastatin A
More description
DCC1122 brd2761
Positive control for HSPC toxicity; Inhibitor of STK33
More description
DCC1121 Brd2577
Novel HDAC inhibitor, inhibiting multiple HDAC enzymes and modulates acetylation levels in cells
More description
DCC1120 Brd20322
Novel potent inhibitor of spCas9, disrupting spCas9-DNA binding and exerting dose and temporal control of spCas9 in human cell lines
More description
DCC1119 Brd0761
Novel Inhibitor of Clostridium difficile
More description
DCC1118 Brd0026
Novel multistage antimalarial inhibitor
More description
DCC1117 Brazilein
Natural small molecule isolated from dried heartwood of Caesalpinia sappan L, exhibiting multi-pharmacological activities
More description
DCC1116 Brassilexin
Inhibitor of cyclobrassinin hydrolase, a unique enzyme from the fungal pathogen Alternaria brassicicola
More description
DCC1115 Brasofensine Maleate
Monoamine Reuptake Inhibitor
More description
DCC1113 bractelactone
Novel potent inhibitor of human neutrophil activations
More description
DCC1112 Bpyo-34
Novel apoptosis signal-regulating kinase 1 (ASK1) inhibitor with IC50 of 0.52μM in vitro in kinase assay
More description
DCC1111 Bpv(pic)k2
Potent and se;rctive PTEN inhibitor, activating the insulin receptor kinase, inhibiting the dephosphorylation of autophosphorylated insulin receptors and epidermal growth factor receptors of rat liver endosomes
More description
DCC1110 Bpv(phen)
Potent direct PTEN inhibitor
More description
DCC1109 Bpr1k871
Novel potent and selective dual FLT3/AURKA inhibitor
More description
DCC1107 bpmetap1-in-15
The first potent inhibitor of Burkholderia pseudomallei methionine aminopeptidase
More description
DCC1106 Bph-652 Potassium
Squalene synthase (SQS) inhibitor, potently inhibiting CrtM
More description
DCC1105 Bph-651
Novel CrtM inhibitor
More description
DCC1104 Bph-1218
Novel potent SQS inhibitor
More description
DCC1103 Bpc Hydroiodide
Novel modulator of TTD-PHD histone reader module, binding to the TTD groove, competing with linker binding and promoting open TTD-PHD conformations
More description
DCC1102 Bp2-94
Histamine H3 receptor agonist prodrug
More description
DCC1101 Bp13944
Novel, Potential Dengue Virus NS2B/NS3 Protease Inhibitor
More description
DCC1100 Bp-1-108
Potent and selective STAT5 inhibitor
More description
DCC1099 Bp1.4160
Novel and highly potent histamine H3 receptor ligand
More description
DCC1098 Bot-64
Novel IKK-2 inhibitor, targeting the Ser177 and/or Ser181 residues in the kinase's activation loop domain.
More description
DCC1097 Bos-6-2-2-6-crbn
Proteolysis targeting chimeras (PROTAC), acting as a degrader of oncogenic BCR-ABL
More description
DCC1096 Bos-318
Novel. highly potent, selective, cell-permeable furin inhibitor, rescuing key features of cystic fibrosis airway disease
More description
DCC1095 Bop-jf549
Novel BOP-conjufated fluorescent dual α9β1/α4β1 integrin inhibitor
More description
DCC1094 Bont-in-33
Novel potent inhibitor of Botulinum neurotoxin/A light chain (BoNT/A LC)
More description
DCC1093 Bont/a Lc Inhibitor 33
Potent Botulinum Neurotoxin A Light-Chain Inhibitor
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X